Drug Pipeline

IBI343 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06238843 A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's… Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Active, Not Recruiting
Phase 2
NCT07415525 IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable… Pancreatic Cancer Not Yet Recruiting
Phase 1/2
NCT07312422 LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A… Pancreatic Cancer Recruiting
Phase 1
NCT05458219 A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or… Locally Advanced Unresectable or Metastatic Solid Tumors Recruiting
Sponsors Running IBI343 Trials
Disease Areas
Get alerts when IBI343 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free